Showing results (1101-1110 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|December 13, 2024
The emerging role of TIM-3 in colorectal cancer: a promising target for immunotherapyReza Karami, Mehrdad Fathi, Pooya Jalali, et al.Expert Opinion on Therapeutic Targets|December 5, 2024
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging dataAshley N Spirrison, Deborah A LanniganExpert Opinion on Therapeutic Targets|December 11, 2023
XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinomaZahra Hendi, Pedram Asadi Sarabi, David Hay, et al.Expert Opinion on Therapeutic Targets|December 9, 2023
Advances in targeting the extracellular matrix for glaucoma therapy: current updatesRenu Agarwal, Igor IezhitsaExpert Opinion on Therapeutic Targets|January 18, 2024
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targetsAlessandra Merlini, Martina Rabino, Silvia Brusco, et al.Expert Opinion on Therapeutic Targets|January 18, 2024
Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancerLin Chen, Tian Fan, Miao Wang, et al.Expert Opinion on Therapeutic Targets|March 12, 2024
Guillain-Barré syndrome: immunopathogenesis and therapeutic targetsShan Liu, Wei Wei Zhang, Linpei Jia, et al.Expert Opinion on Therapeutic Targets|September 23, 2024
Target potential of miRNAs in ulcerative colitis: what do we know?Peeyush Kumar, Saurabh Kedia, Vineet AhujaExpert Opinion on Therapeutic Targets|September 24, 2024
The endocannabinoid system as a therapeutic target in neuropathic pain: a reviewJose-Manuel Quintero, Luis-Eduardo Diaz, Ismael Galve-Roperh, et al.Expert Opinion on Therapeutic Targets|November 17, 2023
CDK6: an attractive therapeutic target for T-ALL/LBLWei Li, Jamie Katy Hu, Miaofen G HuPageof 232